Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn

Background: Hemolytic disease of the newborn (HDN) is a common condition that can have a severe impact on the health of newborns due to the hemolytic reactions it triggers. Although numerous studies have focused on understanding the pathogenesis of HDN, there are still many unanswered questions.Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Shipeng Zhang, Sijin Li, Xuan Meng, Jia Chen, Yan Tang, Xiaobin Li
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2360339
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061198041546752
author Shipeng Zhang
Sijin Li
Xuan Meng
Jia Chen
Yan Tang
Xiaobin Li
author_facet Shipeng Zhang
Sijin Li
Xuan Meng
Jia Chen
Yan Tang
Xiaobin Li
author_sort Shipeng Zhang
collection DOAJ
description Background: Hemolytic disease of the newborn (HDN) is a common condition that can have a severe impact on the health of newborns due to the hemolytic reactions it triggers. Although numerous studies have focused on understanding the pathogenesis of HDN, there are still many unanswered questions.Methods: In this retrospective study, serum samples were collected from 15 healthy newborns and 8 infants diagnosed with hemolytic disease. The relationship between different metabolites and various IgG subtypes in Healthy, HDN and BLI groups was studied by biochemical technique and enzyme-linked immunosorbent assay (ELISA). Metabolomics analysis was conducted to identify the differential metabolites associated with HDN. Subsequently, Pearson's correlation analysis was used to determine the relation of these differential metabolites with IgG isoforms. The relationship between the metabolites and IgG subtypes was observed after treatment.Results: The study results revealed that infants with hemolytic disease exhibited abnormal elevations in TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4 levels when compared to healthy newborns. Additionally, differences in metabolite contents were also observed. N, N-DIMETHYLARGININE showed negative correlations with TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4, while 2-HYDROXYBUTYRATE, AMINOISOBUTANOATE, Inosine, and ALLYL ISOTHIOCYANATE exhibited positive correlations with TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4. Through metabolomics-based research, we have discovered associations between differential metabolites and different IgG isoforms during the onset of HDN.Conclusion: These findings suggest that changes in metabolite and IgG isoform levels are linked to HDN. Understanding the involvement of IgG isoforms and metabolites can provide valuable guidance for the diagnosis and treatment of HDN.
format Article
id doaj-art-e095cc408b934d4fb15b772c1fdace0f
institution DOAJ
issn 1607-8454
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Hematology
spelling doaj-art-e095cc408b934d4fb15b772c1fdace0f2025-08-20T02:50:19ZengTaylor & Francis GroupHematology1607-84542024-12-0129110.1080/16078454.2024.2360339Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newbornShipeng Zhang0Sijin Li1Xuan Meng2Jia Chen3Yan Tang4Xiaobin Li5Zhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaZhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaZhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaZhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaZhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaZhuzhou 331 hospital, Zhuzhou, People’s Republic of ChinaBackground: Hemolytic disease of the newborn (HDN) is a common condition that can have a severe impact on the health of newborns due to the hemolytic reactions it triggers. Although numerous studies have focused on understanding the pathogenesis of HDN, there are still many unanswered questions.Methods: In this retrospective study, serum samples were collected from 15 healthy newborns and 8 infants diagnosed with hemolytic disease. The relationship between different metabolites and various IgG subtypes in Healthy, HDN and BLI groups was studied by biochemical technique and enzyme-linked immunosorbent assay (ELISA). Metabolomics analysis was conducted to identify the differential metabolites associated with HDN. Subsequently, Pearson's correlation analysis was used to determine the relation of these differential metabolites with IgG isoforms. The relationship between the metabolites and IgG subtypes was observed after treatment.Results: The study results revealed that infants with hemolytic disease exhibited abnormal elevations in TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4 levels when compared to healthy newborns. Additionally, differences in metabolite contents were also observed. N, N-DIMETHYLARGININE showed negative correlations with TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4, while 2-HYDROXYBUTYRATE, AMINOISOBUTANOATE, Inosine, and ALLYL ISOTHIOCYANATE exhibited positive correlations with TBA, IgG1, IgG2a, IgG2b, IgG3, and IgG4. Through metabolomics-based research, we have discovered associations between differential metabolites and different IgG isoforms during the onset of HDN.Conclusion: These findings suggest that changes in metabolite and IgG isoform levels are linked to HDN. Understanding the involvement of IgG isoforms and metabolites can provide valuable guidance for the diagnosis and treatment of HDN.https://www.tandfonline.com/doi/10.1080/16078454.2024.2360339HDNTBAIgGmetabolomics
spellingShingle Shipeng Zhang
Sijin Li
Xuan Meng
Jia Chen
Yan Tang
Xiaobin Li
Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
Hematology
HDN
TBA
IgG
metabolomics
title Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
title_full Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
title_fullStr Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
title_full_unstemmed Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
title_short Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn
title_sort metabolomics based study on the significance of differential metabolite binding igg isoforms in hemolytic disease of newborn
topic HDN
TBA
IgG
metabolomics
url https://www.tandfonline.com/doi/10.1080/16078454.2024.2360339
work_keys_str_mv AT shipengzhang metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn
AT sijinli metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn
AT xuanmeng metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn
AT jiachen metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn
AT yantang metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn
AT xiaobinli metabolomicsbasedstudyonthesignificanceofdifferentialmetabolitebindingiggisoformsinhemolyticdiseaseofnewborn